Knockdown of TIPE2 increases the proliferation in lipopolysaccharide-stimulated gastric cancer cells

about

Knockdown of TIPE2 increases the proliferation in lipopolysaccharide-stimulated gastric cancer cells

Item

http://www.wikidata.org/entity/Q58694995

description

im August 2018 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 29 August 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

Knockdown of TIPE2 increases t ...... timulated gastric cancer cells

@en

Knockdown of TIPE2 increases t ...... timulated gastric cancer cells

@nl

type

Item

label

Knockdown of TIPE2 increases t ...... timulated gastric cancer cells

@en

Knockdown of TIPE2 increases t ...... timulated gastric cancer cells

@nl

prefLabel

Knockdown of TIPE2 increases t ...... timulated gastric cancer cells

@en

Knockdown of TIPE2 increases t ...... timulated gastric cancer cells

@nl

P1476

Knockdown of TIPE2 increases t ...... timulated gastric cancer cells

@en

P2093

Dongyan Shen

http://www.w3.org/2001/XMLSchema#string

Wei Huang

http://www.w3.org/2001/XMLSchema#string

Wenming Liu

http://www.w3.org/2001/XMLSchema#string

Xiaoxiao Huang

http://www.w3.org/2001/XMLSchema#string

Yanyun Fan

http://www.w3.org/2001/XMLSchema#string

Ying Shi

http://www.w3.org/2001/XMLSchema#string

Zhenhe Lin

http://www.w3.org/2001/XMLSchema#string

P2860

Identical expression profiling of human and murine TIPE3 protein reveals links to its functions

Comprehensive molecular characterization of gastric adenocarcinoma

TIPE3 is the transfer protein of lipid second messengers that promote cancer

Expression and roles of TIPE2 in autoimmune hepatitis.

Tumor necrosis factor-α-induced protein 8-like 2 (TIPE2) is associated with immune phases of patients with chronic hepatitis B.

Chronicles of a cancer foretold: 35 years of gastric cancer risk assessment

The incidences and mortalities of major cancers in China, 2009.

Hepatitis C virus promotes hepatocellular carcinogenesis by targeting TIPE2, a new regulator of DNA damage response.

TIPE2 suppresses angiogenesis and non-small cell lung cancer (NSCLC) invasiveness via inhibiting Rac1 activation and VEGF expression.

The TIPE (TNFAIP8) family in inflammation, immunity, and cancer.

P2888

s12885-018-4761-3

P304

857

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12885-018-4761-3

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Z Qi

P577

2018-08-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1106411245

http://www.w3.org/2001/XMLSchema#string

P698

30157801

http://www.w3.org/2001/XMLSchema#string

P921

cancer research

lipopolysaccharide

P932

6116435

http://www.w3.org/2001/XMLSchema#string